CRYSTAL MCVAY: Open Payments
NPI 1710405519 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 19 payments from 12 companies in 2025. Trend: 2023 $874 · 2024 $289 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Theratechnologies Inc. | 3 | $91 |
| Melinta Therapeutics, LLC | 3 | $81 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Aimmune Therapeutics, Inc. | 2 | $38 |
| Gilead Sciences, Inc. | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Smith+Nephew, Inc. | 1 | $21 |
| HARTMANN USA, INC. | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Philips North America LLC | 1 | $16 |
Products named: EGRIFTA, Kimyrsa, DUPIXENT, VOWST, Rezzayo, ZERBAXA, COLLAGENASE SANTYL, ZETUVIT PLUS 10X10 P10.
Industry payments across FL — which companies pay providers there.
